Cargando…

Variant constraint by mRNA vaccines

The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.

Detalles Bibliográficos
Autor principal: Bordon, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034506/
https://www.ncbi.nlm.nih.gov/pubmed/33837367
http://dx.doi.org/10.1038/s41577-021-00548-5
_version_ 1783676555066605568
author Bordon, Yvonne
author_facet Bordon, Yvonne
author_sort Bordon, Yvonne
collection PubMed
description The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.
format Online
Article
Text
id pubmed-8034506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80345062021-04-12 Variant constraint by mRNA vaccines Bordon, Yvonne Nat Rev Immunol Research Highlight The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants. Nature Publishing Group UK 2021-04-09 2021 /pmc/articles/PMC8034506/ /pubmed/33837367 http://dx.doi.org/10.1038/s41577-021-00548-5 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
Bordon, Yvonne
Variant constraint by mRNA vaccines
title Variant constraint by mRNA vaccines
title_full Variant constraint by mRNA vaccines
title_fullStr Variant constraint by mRNA vaccines
title_full_unstemmed Variant constraint by mRNA vaccines
title_short Variant constraint by mRNA vaccines
title_sort variant constraint by mrna vaccines
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034506/
https://www.ncbi.nlm.nih.gov/pubmed/33837367
http://dx.doi.org/10.1038/s41577-021-00548-5
work_keys_str_mv AT bordonyvonne variantconstraintbymrnavaccines